(BC) Brunswick - Overview
Sector: Consumer Cyclical | Industry: Recreational Vehicles | Exchange: NYSE (USA) | Market Cap: 4.775m USD | Total Return: 61.7% in 12m
Avg Turnover: 45.5M
EPS Trend: -96.2%
Qual. Beats: 1
Rev. Trend: -84.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Brunswick Corporation (NYSE: BC) is a vertically integrated manufacturer and distributor of marine recreation products, operating through four distinct segments: Propulsion, Engine Parts & Accessories (P&A), Navico Group, and Boat. The company maintains a portfolio of established brands including Mercury Marine, Boston Whaler, Sea Ray, and the Freedom Boat Club. Its business model covers the entire marine lifecycle, from engine manufacturing and electronic systems integration to boat assembly and subscription-based boat club services.
The leisure marine sector is characterized by high cyclicality and is sensitive to interest rate fluctuations and consumer discretionary spending levels. Unlike many competitors, Brunswick utilizes a diversified revenue stream that includes aftermarket parts and consumables, which typically provides more stable margins during periods of lower new-boat demand. The company also supplies electrical and power systems to the recreational vehicle (RV) and industrial markets, reducing its total reliance on the marine industry.
Investors looking for deeper insights into the companys valuation metrics might consider exploring the data available on ValueRay. Brunswick Corporation remains headquartered in Mettawa, Illinois, and has been in operation since 1845.
- High interest rates and tightening credit reduce consumer demand for discretionary marine products
- Mercury Marine propulsion market share gains drive high-margin revenue growth in outboard engines
- Expansion of Freedom Boat Club recurring revenue model provides hedge against cyclical sales
- Navico Group integration and electrical system sales diversify revenue beyond traditional boat manufacturing
| Net Income: -136.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.76 > 1.0 |
| NWC/Revenue: 11.31% < 20% (prev 16.45%; Δ -5.13% < -1%) |
| CFO/TA 0.10 > 3% & CFO 525.4m > Net Income -136.5m |
| Net Debt (2.30b) to EBITDA (601.4m): 3.82 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.7m) vs 12m ago -0.90% < -2% |
| Gross Margin: 24.21% > 18% (prev 0.25%; Δ 2.40k% > 0.5%) |
| Asset Turnover: 97.14% > 50% (prev 86.97%; Δ 10.17% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBITDA TTM 601.4m / Interest Expense TTM 106.6m) |
| A: 0.11 (Total Current Assets 2.29b - Total Current Liabilities 1.66b) / Total Assets 5.51b |
| B: 0.61 (Retained Earnings 3.36b / Total Assets 5.51b) |
| C: 0.05 (EBIT TTM 304.1m / Avg Total Assets 5.68b) |
| D: 0.88 (Book Value of Equity 3.42b / Total Liabilities 3.90b) |
| Altman-Z'' = 4.01 = AA |
| DSRI: 1.07 (Receivables 638.8m/553.1m, Revenue 5.52b/5.09b) |
| GMI: 1.02 (GM 24.21% / 24.73%) |
| AQI: 0.92 (AQ_t 0.34 / AQ_t-1 0.37) |
| SGI: 1.08 (Revenue 5.52b / 5.09b) |
| TATA: -0.12 (NI -136.5m - CFO 525.4m) / TA 5.51b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 80.96 with a total of 519,127 shares traded.
Over the past week, the price has changed by +4.99%,
over one month by +1.21%,
over three months by -2.29% and
over the past year by +61.74%.
Brunswick has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold BC.
- StrongBuy: 5
- Buy: 3
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 90.1 | 11.3% |
P/S = 0.8652
P/B = 3.1463
P/EG = 0.7151
Revenue TTM = 5.52b USD
EBIT TTM = 304.1m USD
EBITDA TTM = 601.4m USD
Long Term Debt = 1.81b USD (from longTermDebt, last quarter)
Short Term Debt = 490.2m USD (from shortTermDebt, last quarter)
Debt = 2.59b USD (from shortLongTermDebtTotal, last quarter) + Leases 145.3m
Net Debt = 2.30b USD (calculated: Debt 2.59b - CCE 289.3m)
Enterprise Value = 7.07b USD (4.77b + Debt 2.59b - CCE 289.3m)
Interest Coverage Ratio = 2.85 (Ebit TTM 304.1m / Interest Expense TTM 106.6m)
EV/FCF = 20.80x (Enterprise Value 7.07b / FCF TTM 340.1m)
FCF Yield = 4.81% (FCF TTM 340.1m / Enterprise Value 7.07b)
FCF Margin = 6.16% (FCF TTM 340.1m / Revenue TTM 5.52b)
Net Margin = -2.47% (Net Income TTM -136.5m / Revenue TTM 5.52b)
Gross Margin = 24.21% ((Revenue TTM 5.52b - Cost of Revenue TTM 4.18b) / Revenue TTM)
Gross Margin QoQ = 24.93% (prev 23.08%)
Tobins Q-Ratio = 1.28 (Enterprise Value 7.07b / Total Assets 5.51b)
Interest Expense / Debt = 4.12% (Interest Expense 106.6m / Debt 2.59b)
Taxrate = 21.93% (5.90m / 26.9m)
NOPAT = 237.4m (EBIT 304.1m * (1 - 21.93%))
Current Ratio = 1.38 (Total Current Assets 2.29b / Total Current Liabilities 1.66b)
Debt / Equity = 1.62 (Debt 2.59b / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = 3.82 (Net Debt 2.30b / EBITDA 601.4m)
Debt / FCF = 6.76 (Net Debt 2.30b / FCF TTM 340.1m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.40% (Net Income -136.5m / Total Assets 5.51b)
RoE = -5.12% (Net Income TTM -136.5m / Total Stockholder Equity 2.66b)
RoCE = 6.80% (EBIT 304.1m / Capital Employed (Equity 2.66b + L.T.Debt 1.81b))
RoIC = 5.65% (NOPAT 237.4m / Invested Capital 4.20b)
WACC = 8.57% (E(4.77b)/V(7.36b) * Re(11.47%) + D(2.59b)/V(7.36b) * Rd(4.12%) * (1-Tc(0.22)))
Discount Rate = 11.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.28 | Cagr: -2.22%
[DCF] Terminal Value 72.28% ; FCFF base≈366.6m ; Y1≈321.5m ; Y5≈259.7m
[DCF] Fair Price = 26.55 (EV 4.02b - Net Debt 2.30b = Equity 1.73b / Shares 65.0m; r=8.57% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -96.24 | EPS CAGR: -37.66% | SUE: 1.76 | # QB: 1
Revenue Correlation: -83.95 | Revenue CAGR: -9.07% | SUE: 0.58 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.20 | Chg30d=-21.52% | Revisions=-79% | Analysts=17
EPS next Quarter (2026-09-30): EPS=1.45 | Chg30d=+4.87% | Revisions=+58% | Analysts=17
EPS current Year (2026-12-31): EPS=4.26 | Chg30d=+1.06% | Revisions=+50% | GrowthEPS=+30.4% | GrowthRev=+7.2%
EPS next Year (2027-12-31): EPS=5.33 | Chg30d=+1.96% | Revisions=+44% | GrowthEPS=+25.1% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: -79%